Trending Now
Business
Cleveland Browns Mychal Kendricks, Goldman Analyst Charged In $1.2MM Insider Trading...
Professional sports leagues, particularly the NFL, are sitting in the catbird seat. Through TV contracts, online streaming deals and now sports betting, the NFL...
Oracle: It’s All About The Cloud
Oracle (ORCL) reports quarterly earnings after-hours. Analysts expect revenue of $9.78 billion and eps of $0.72. The revenue estimate implies about 2% growth sequentially....
Lifestyle today
Entertainment
Mallinckrodt: Impact Of $1.2 Billion Sucampo Deal Could Be Ethereal
After Mallinckrodt (MNK) experienced cracks in Acthar sales I all but left the company for dead. Last week it announced it expected up to...
Trump Insults LeBron Before Ohio Campaign Rally
President Trump and Los Angeles Lakers LeBron James are locked a public war of words over sports, race, the National Anthem and frankly, who...
Tom Brady, Jalen Ramsey Talk Hella Reckless During Warm-Ups
The AFC and NFC championship games are both being played today. In the NFC the Philadelphia Eagles take on the Minnesota Vikings, while the...
Does Recent Asset Sale Reflect Mallinckrodt’s Desperate Measures?
Mallinckrodt (MNK) recently signed an agreement to sell hemostasis products RECOTHROM Thrombin topical (Recombinant) and PREVELEAK Surgical Sealant to Baxter (BAX) for about $185...
Shock Exchange Predicted The College Admissions Scandal
The elite college admissions scandal has rocked the country and dominated the 24 hour news cycle. Wealthy parents are accused of paying hefty sums...
How Warren Buffett Triggered Teva’s Epic Short Squeeze
The opioid epidemic continues to dominate the public discourse. The question remains, "What can be done about it?" The number of accidental deaths related...
Mallinckrodt Is Under Siege
Tuesday a Delaware judge invalidated 11 patents for Mallinkrodt's (MNK) top-selling drug Inomax. The news sent the stock down over 12%:
Shares of pharmaceutical company...
Insurer Refutes Claims For Fake Opioid Lawsuit
Former president Donald Trump was highly critical of opioid drug manufacturers. He wanted to shed more light on their role in the...























































































































